Skip to main content
European Commission logo print header

Novel Stromal Cell Therapy for Diabetic Kidney Disease

Risultati finali

Dissemination materials

Dissemination materials brochure flyer posters newsletters

Website

Website updated throughout the project

Pubblicazioni

Effects of mesenchymal stromal cells on regulatory T cells: Current understanding and clinical relevance

Autori: Neema Negi, Matthew D. Griffin
Pubblicato in: STEM CELLS, Issue 38/5, 2020, Page(s) 596-605, ISSN 1066-5099
Editore: AlphaMed Press Inc
DOI: 10.1002/stem.3151

Mesenchymal stromal cell–based therapies for acute kidney injury: progress in the last decade

Autori: Barbara Fazekas, Matthew D. Griffin
Pubblicato in: Kidney International, Issue 97/6, 2020, Page(s) 1130-1140, ISSN 0085-2538
Editore: Blackwell Publishing Inc.
DOI: 10.1016/j.kint.2019.12.019

The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review

Autori: Sarah Elshahat, Paul Cockwell, Alexander P. Maxwell, Matthew Griffin, Timothy O’Brien, Ciaran O’Neill
Pubblicato in: PLOS ONE, Issue 15/3, 2020, Page(s) e0230512, ISSN 1932-6203
Editore: Public Library of Science
DOI: 10.1371/journal.pone.0230512

Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe

Autori: Tomás P Griffin, Paula M O'Shea, Andrew Smyth, Md Nahidul Islam, Deirdre Wall, John Ferguson, Esther O'Sullivan, Francis M Finucane, Sean F Dinneen, Fidelma P Dunne, David W Lappin, Donal N Reddan, Marcia Bell, Timothy O'Brien, Damian G Griffin, Matthew D Griffin
Pubblicato in: BMJ Open Diabetes Research & Care, Issue 9/1, 2021, Page(s) e002125, ISSN 2052-4897
Editore: BMJ Open Diabetes Research and Care
DOI: 10.1136/bmjdrc-2021-002125

Chronic kidney disease

Autori: Paola Romagnani, Giuseppe Remuzzi, Richard Glassock, Adeera Levin, Kitty J. Jager, Marcello Tonelli, Ziad Massy, Christoph Wanner, Hans-Joachim Anders
Pubblicato in: Nature Reviews Disease Primers, Issue 3, 2017, Page(s) 17088, ISSN 2056-676X
Editore: Nature Reviews
DOI: 10.1038/nrdp.2017.88

Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?

Autori: Paul Lohan, Oliver Treacy, Matthew D. Griffin, Thomas Ritter, Aideen E. Ryan
Pubblicato in: Frontiers in Immunology, Issue 8, 2017, ISSN 1664-3224
Editore: Frontiers in Immunology
DOI: 10.3389/fimmu.2017.01626

Influence of Referral to a Combined Diabetology and Nephrology Clinic on Renal Functional Trends and Metabolic Parameters in Adults With Diabetic Kidney Disease

Autori: William P. Martin, Tomás P. Griffin, David W. Lappin, Damian G. Griffin, John P. Ferguson, Timothy O'Brien, Matthew D. Griffin
Pubblicato in: Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Issue 1/2, 2017, Page(s) 150-160, ISSN 2542-4548
Editore: Elsevier
DOI: 10.1016/j.mayocpiqo.2017.07.003

Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat

Autori: Paul Lohan, Oliver Treacy, Maurice Morcos, Ellen Donohoe, Yvonne O'donoghue, Aideen E. Ryan, Stephen J. Elliman, Thomas Ritter, Matthew D. Griffin
Pubblicato in: STEM CELLS, 2018, ISSN 1066-5099
Editore: AlphaMed Press Inc
DOI: 10.1002/stem.2840

Hyperactivation of nuclear receptor coactivators induces PERK-dependent cell death

Autori: Muhammad Mosaraf Hossain, David Barua, Vahid Arabkari, Nahidul Islam, Ananya Gupta, Sanjeev Gupta
Pubblicato in: Oncotarget, Issue 9/14, 2018, ISSN 1949-2553
Editore: Impact Journals
DOI: 10.18632/oncotarget.24451

Anti-donor antibody induction following intramuscular injections of allogeneic mesenchymal stromal cells

Autori: Senthilkumar Alagesan, Clara Sanz-Nogués, Xizhe Chen, Michael Creane, Thomas Ritter, Rhodri Ceredig, Timothy O'Brien, Matthew D Griffin
Pubblicato in: Immunology and Cell Biology, Issue 96/5, 2018, Page(s) 536-548, ISSN 0818-9641
Editore: Blackwell Publishing Inc.
DOI: 10.1111/imcb.12024

Phenotypic and functional heterogeneity of human intermediate monocytes based on HLA-DR expression

Autori: Eanna P Connaughton, Serika Naicker, Shirley A Hanley, Stephanie M Slevin, John K Eykelenboom, Noel F Lowndes, Timothy O'Brien, Rhodri Ceredig, Matthew D Griffin, Michael C Dennedy
Pubblicato in: Immunology and Cell Biology, 2018, ISSN 0818-9641
Editore: Blackwell Publishing Inc.
DOI: 10.1111/imcb.12032

The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease

Autori: Tomás P. Griffin, William Patrick Martin, Nahidul Islam, Timothy O’Brien, Matthew D. Griffin
Pubblicato in: Current Diabetes Reports, Issue 16/5, 2016, ISSN 1534-4827
Editore: Current Science Inc.
DOI: 10.1007/s11892-016-0734-6

Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology

Autori: Norberto Perico, Federica Casiraghi, Giuseppe Remuzzi
Pubblicato in: Journal of the American Society of Nephrology, Issue 29/2, 2018, Page(s) 362-375, ISSN 1046-6673
Editore: Lippincott Williams & Wilkins Ltd.
DOI: 10.1681/ASN.2017070781

Mesenchymal Stromal Cells for AKI after Cardiac Surgery

Autori: Norberto Perico, Federica Casiraghi, Giuseppe Remuzzi
Pubblicato in: Journal of the American Society of Nephrology, 2018, Page(s) ASN.2017111207, ISSN 1046-6673
Editore: Lippincott Williams & Wilkins Ltd.
DOI: 10.1681/ASN.2017111207

The Immune System in Tissue Environments Regaining Homeostasis after Injury: Is “Inflammation” Always Inflammation?

Autori: Onkar P. Kulkarni, Julia Lichtnekert, Hans-Joachim Anders, Shrikant R. Mulay
Pubblicato in: Mediators of Inflammation, Issue 2016, 2016, Page(s) 1-9, ISSN 0962-9351
Editore: Hindawi Publishing Corporation
DOI: 10.1155/2016/2856213

Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England

Autori: Nga T. Q. Nguyen, Paul Cockwell, Alexander P. Maxwell, Matthew Griffin, Timothy O’Brien, Ciaran O’Neill
Pubblicato in: PLOS ONE, Issue 13/11, 2018, Page(s) e0207960, ISSN 1932-6203
Editore: Public Library of Science
DOI: 10.1371/journal.pone.0207960

Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD)

Autori: Siobhan M. Hamon, Tomás P. Griffin, Md Nahidul Islam, Deirdre Wall, Matthew D. Griffin, Paula M. O’Shea
Pubblicato in: Clinical Chemistry and Laboratory Medicine (CCLM), Issue 0/0, 2018, ISSN 1434-6621
Editore: Walter de Gruyter GmbH & Co. KG
DOI: 10.1515/cclm-2018-0534

Effect of Sodium Glucose Co-Transporter-2 Inhibition on the Aldosterone/Renin Ratio in Type 2 Diabetes Mellitus

Autori: Tomás Griffin, Md Islam, Liam Blake, Marcia Bell, Matthew Griffin, Paula O’Shea
Pubblicato in: Hormone and Metabolic Research, Issue 51/02, 2019, Page(s) 91-99, ISSN 0018-5043
Editore: Georg Thieme Verlag
DOI: 10.1055/a-0794-7026

Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody

Autori: A. Liew, C. Baustian, D. Thomas, E. Vaughan, C. Sanz-Nogués, M. Creane, X. Chen, S. Alagesan, P. Owens, J. Horan, P. Dockery, M. D. Griffin, A. Duffy, T. O’Brien
Pubblicato in: Cell Transplantation, 2018, Page(s) 096368971878486, ISSN 0963-6897
Editore: Cognizant Communication Corp.
DOI: 10.1177/0963689718784862

Mesenchymal Stromal Cells for Transplant Tolerance

Autori: Manuel Alfredo Podestà, Giuseppe Remuzzi, Federica Casiraghi
Pubblicato in: Frontiers in Immunology, Issue 10, 2019, ISSN 1664-3224
Editore: Frontiers in Immunology
DOI: 10.3389/fimmu.2019.01287

Progress toward the clinical application of mesenchymal stromal cells and other disease-modulating regenerative therapies

Autori: LaTonya J. Hickson, Sandra M. Herrmann, Bairbre A. McNicholas, Matthew D. Griffin
Pubblicato in: Kidney360, 2021, Page(s) 10.34067/KID.0005692020, ISSN 2641-7650
Editore: American Society of Nephrology
DOI: 10.34067/kid.0005692020

Human mesenchymal stromal cells broadly modulate high glucose-induced inflammatory responses of renal proximal tubular cell monolayers

Autori: Md Nahidul Islam, Tomás P. Griffin, Elizabeth Sander, Stephanie Rocks, Junaid Qazi, Joana Cabral, Jasmin McCaul, Tara McMorrow, Matthew D. Griffin
Pubblicato in: Stem Cell Research & Therapy, Issue 10/1, 2019, Page(s) online, ISSN 1757-6512
Editore: BioMed Central
DOI: 10.1186/s13287-019-1424-5

Plasma dephosphorylated-uncarboxylated Matrix Gla-Protein (dp-ucMGP): reference intervals in Caucasian adults and diabetic kidney disease biomarker potential

Autori: Tomás Patrick Griffin, Md Nahidul Islam, Deirdre Wall, John Ferguson, Damian Gerard Griffin, Matthew Dallas Griffin, Paula M. O’Shea
Pubblicato in: Scientific Reports, Issue 9/1, 2019, Page(s) online, ISSN 2045-2322
Editore: Nature Publishing Group
DOI: 10.1038/s41598-019-54762-2

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation

Autori: Matthew D. Griffin, Sundararaman Swaminathan
Pubblicato in: Frontiers in Pharmacology, Issue 11, 2020, Page(s) online, ISSN 1663-9812
Editore: Frontiers Media S.A.
DOI: 10.3389/fphar.2020.00038

È in corso la ricerca di dati su OpenAIRE...

Si è verificato un errore durante la ricerca dei dati su OpenAIRE

Nessun risultato disponibile